Johnson Matthey’s (JMAT) Buy Rating Reaffirmed at Jefferies Financial Group

Jefferies Financial Group reiterated their buy rating on shares of Johnson Matthey (LON:JMATFree Report) in a research note released on Tuesday, MarketBeat.com reports. They currently have a GBX 1,800 ($22.88) target price on the stock.

Separately, Berenberg Bank cut their price objective on shares of Johnson Matthey from GBX 1,650 ($20.98) to GBX 1,500 ($19.07) and set a “hold” rating on the stock in a report on Thursday, November 28th.

View Our Latest Research Report on JMAT

Johnson Matthey Stock Down 1.4 %

LON:JMAT opened at GBX 1,378 ($17.52) on Tuesday. The company has a debt-to-equity ratio of 63.15, a current ratio of 1.45 and a quick ratio of 0.76. Johnson Matthey has a 1-year low of GBX 1,318 ($16.76) and a 1-year high of GBX 1,917.07 ($24.37). The company has a 50-day moving average of GBX 1,477.53 and a 200 day moving average of GBX 1,574.53. The firm has a market cap of £2.40 billion, a PE ratio of 2,375.86, a price-to-earnings-growth ratio of 49,242.50 and a beta of 0.95.

Johnson Matthey Cuts Dividend

The company also recently disclosed a dividend, which will be paid on Tuesday, February 4th. Investors of record on Thursday, December 5th will be given a dividend of GBX 22 ($0.28) per share. This represents a yield of 1.47%. The ex-dividend date is Thursday, December 5th. Johnson Matthey’s payout ratio is currently 13,275.86%.

Insider Buying and Selling

In related news, insider Liam Condon purchased 27 shares of the business’s stock in a transaction dated Wednesday, October 16th. The stock was acquired at an average price of GBX 1,505 ($19.13) per share, for a total transaction of £406.35 ($516.59). Also, insider Stephen Oxley sold 19,554 shares of the stock in a transaction that occurred on Friday, October 18th. The stock was sold at an average price of GBX 1,526 ($19.40), for a total value of £298,394.04 ($379,346.61). Over the last three months, insiders acquired 7,458 shares of company stock worth $10,024,332. Company insiders own 0.61% of the company’s stock.

About Johnson Matthey

(Get Free Report)

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.

See Also

Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.